Reprogramming Myeloid Cells for Cancer: CAR-M from Ex Vivo to In Vivo

Time: 3:00 pm
day: Conference Day One

Details:

  • Targeting macrophages with CARs for solid tumors
  • Investigating pre-clinical and clinical data with ex vivo CAR-M cell therapies
  • Describing our in vivo CAR-M platform that is being developed in partnership with Moderna

Speakers: